Updated Oct 28, 2026 · 12:56 UTC
NVAXNovavax, Inc.
Health Care · United States · XNAS · biological products, (no diagnostic substances)
$10.00+6.60%last session · market early-hours
Market cap
$1.64b
real-world
Tokenized
$414
<0.001% of the asset
Avg token price
$182.55
+1725.65% vs real
Spot volume, 24h
$4
1 venues
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
NVAX · Price
EarningsNasdaq’s earnings calendar
Next earnings
Nov 5
estimated date · Sep 2026 quarter · EPS forecast −$0.33 (3 analysts)
Last earnings, Aug 6
−$0.32 EPS
+11.1% vs −$0.36 forecast · Jun 2026 quarter
Real marketNovavax Inc
Last close
$10.02
Oct 27
Traded on Oct 27
$65.5m
Price now
$10.00
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $4 · 1 venue
Aerodrome Slipstream 31 pair$4Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions1 token from 1 issuer
NVAXcCoinbase$182.55$414HoldersAddresses holding its tokens on each chain counted, each token counted and added, issuers’ own addresses left out · the value is what they hold onchain
Base74 holders$414Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$413.8m
−62% YoY
Operating income
−$234.1m
-57% margin
Net income
−$247.7m
-60% margin
EPS, diluted
−$1.51
Diluted shares
165m
−7% YoY
Cash and balance sheet
Operating cash flow
−$36.9m
capital spending not tagged
Net cash
$427.9m
$719.3m cash and securities, $291.5m debt
Quarterly
RevenueNet income
Valuation today’s market cap $1.64b · enterprise value $1.22b
EV / sales
2.9×